Metagenomi Therapeutics, Inc. (MGX) Capital expenditures 2023–2025
Metagenomi Therapeutics, Inc. (MGX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$574,000FY2025 · since FY2023: $9.8M → $574,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $574,000 | -81.6% |
| FY2024 | $3.1M | -68.3% |
| FY2023 | $9.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice